研究生导师介绍姓名：曹飞麟性别:男院系：附属台州医院行政职务：主任专业技术职称：任职年月：2013年3月从事专业1：肿瘤学从事专业2：导师类别：硕士生导师(专业型)最后学历：本科毕业最后学位：学士任硕导年月：任博导年月：是否院士：否是否国务院学科评议组成员：否毕业院校：温州医学院毕业专业：1002临床医学毕业时间：1987年7月办公电话：0576-85199051E-mail：caofl@enzemed.com在职信息：在岗◇本人简历曹飞麟，男，48岁，332621196309120175肿瘤学教授，主任医师，温州医学院附属台州医院甲状腺乳腺外科病区主任。中国医师协会外科学分会甲状腺外科学组委员。浙江省抗癌协会乳腺癌专业委员会常委、浙江省医学会（肿瘤外科分会）委员、台州市医学会肿瘤学组副主任委员、台州市医学重点学科带头人。主要从事甲状腺、乳腺、胃肠道肿瘤的外科和综合治疗。每年开展甲状腺手术近1000台次，乳腺癌手术近200台次。近年发表的SCI论文：1.CaoF,JinK,CuiB,XieB.Learningcurveforendoscopicthyroidectomy:asingleteachinghospitalstudy.OncoTargetsTher.2013;6:47-52.2.CaoF*,XieB,CuiB,XuD.Endoscopicvs.conventionalthyroidectomyforthetreatmentofbenignthyroidtumors:Aretrospectivestudyofa4-yearexperience.ExpTherMed.2011Jul;2(4):661-666.Epub2011May12.3.LanH,JinK,XieB,HanN,CuiB,CaoF*,TengL.Heterogeneitybetweenprimarycoloncarcinomaandpairedlymphaticandhepaticmetastases.MolMedReport.2012;6(5):1057-68.4.LiZ,JinK,YuX,TengX,ZhouH,WangY,TengL,CaoF*.Extranodalfolliculardendriticcellsarcomainmesentery:Acasereport.OncolLett.2011;2(4):649-652.5.XieB,ZhengH,LanH,CuiB,JinK,CaoF*.SynchronousbilateralPaget'sdiseaseofthebreast:Acasereport.OncolLett.2012;4(1):83-85.6.JinK,LanH,CaoF,XuZ,HanN,LiG,HeK,TengL.AntitumoreffectofFP3inapatient-derivedtumortissuexenograftmodelofgastriccarcinomathroughanantiangiogenicmechanism.OncolLett.2012;3(5):1052-1058.7.JinK,GaoW,LuY,LanH,TengL,CaoF*.Mechanismsregulatingcolorectalcancercellmetastasisintoliver(Review).OncolLett.2012;3(1):11-15.8.JinK,LanH,XieB,HeK,XuZ,LiG,HanN,TengL,CaoF*.AntitumoreffectsofFP3incombinationwithcapecitabineonPDTTxenograftmodelsofprimarycoloncarcinomaandrelatedlymphaticandhepaticmetastases.CancerBiolTher.2012;13(9):737-44.9.JinK,LanH,CaoF*,HanN,XuZ,LiG,HeK,TengL.DifferentialresponsetoEGFR-andVEGF-targetedtherapiesinpatient-derivedtumortissuexenograftmodelsofcoloncarcinomaandrelatedmetastases.IntJOncol.2012;41(2):583-8.10.GaoW,JinK,LanH,HanN,CaoF,TengL.FP3:ANovelVEGFBlockerwithAnti-AngiogenicandAnti-TumorEffects.Hepatogastroenterology.2012Apr25;59(120).doi:10.5754/hge12159.[Epubaheadofprint]11.DongX,JinK,HuX,DuF,LanH,HanN,MaZ,XieB,CuiB,TengL,CaoF*.AntitumoreffectofFP3incombinationwithcetuximabonpatient-derivedtumortissuexenograftmodelsofprimarycoloncarcinomaandrelatedlymphaticandhepaticmetastases.IntJMolMed.2012;30(1):126-32.12.DuF,JinK,HuX,DongX,CaoF.Surgicaltreatmentofretrorectaltumors:aretrospectivestudyofaten-yearexperienceinthreeinstitutions.Hepatogastroenterology.2012;59(117):1374-7.13.JinK,LiG,CuiB,ZhangJ,LanH,HanN,XieB,CaoF,HeK,WangH,XuZ,TengL,ZhuT.AssessmentofanovelVEGFtargetedagentusingpatient-derivedtumortissuexenograftmodelsofcoloncarcinomawithlymphaticandhepaticmetastases.PLoSOne.2011;6(12):e28384.◇学术团体任职情况:中国医师协会外科学分会甲状腺外科学组委员。浙江省抗癌协会乳腺癌专业委员会常委、浙江省医学会（肿瘤外科分会）委员、台州市医学会肿瘤学组副主任委员。◇近三年在国内外核心期刊上发表学术论文情况:论文题目刊物名称刊物国家收录情况卷期排名Learningcurveforendoscopicthyroidectomy:asingleteachinghospitalstudy.OncoTargetsTher.国外SCI2013;6:47-521Endoscopicvs.conventionalthyroidectomyforthetreatmentofbenignthyroidtumors:Aretrospectivestudyofa4-yearexperience.ExpTherMed.国外SCI2(4):661-6661Heterogeneitybetweenprimarycoloncarcinomaandpairedlymphaticandhepaticmetastases.MolMedReport.国外SCI6(5):1057-68通讯作者AntitumoreffectsofFP3incombinationwithcapecitabineonPDTTxenograftmodelsofprimarycoloncarcinomaandrelatedlymphaticandhepaticmetastases.CancerBiolTher.国外SCI13(9):737-44通讯作者DifferentialresponsetoEGFR-andVEGF-targetedtherapiesinpatient-derivedtumortissuexenograftmodelsofcoloncarcinomaandrelatedmetastases.IntJOncol.国外SCI41(2):583-8通讯作者AntitumoreffectofFP3incombinationwithcetuximabonpatient-derivedtumortissuexenograftmodelsofprimarycoloncarcinomaandrelatedlymphaticandhepaticmetastases.IntJMolMed.国外SCI30(1):126-32通讯作者Extranodalfolliculardendriticcellsarcomainmesentery:Acasereport.OncolLett.国外SCI2(4):649-652通讯作者SynchronousbilateralPaget'sdiseaseofthebreast:Acasereport.OncolLett.国外SCI4(1):83-85通讯作者AntitumoreffectofFP3inapatient-derivedtumortissuexenograftmodelofgastriccarcinomathroughanantiangiogenicmechanism.OncolLett.国外SCI3(5):1052-1058.3Mechanismsregulatingcolorectalcancercellmetastasisintoliver(Review).OncolLett.国外SCI3(1):11-15通讯作者◇出版专著教材情况(注：在书名后注明教材或专著):名称类别出版单位日期排名◇成果获奖情况:成果名称颁奖部门等级完成日期证书号排名COX-2及VEGF在乳腺癌中的表达及意义其他三等奖09112-11

◇近三完成的科研项目:项目名称任务来源完成形式完成日期鉴定验收单位主要结论排名
◇目前承担的主要项目:项目名称及下达编号项目类别项目来源起讫时间科研经费(万元)本人承担任务：Flt-1及microRNA调控在乳腺癌转移和血管生成中作用机制研究2013-1-2015-1228.002紫杉醇对乳腺癌患者NK细胞免疫调节机理及临床应用的研究2011-1-2013-122.001